OncoK9 Liquid Biopsy

OncoK9 distinguishes itself as a non‑invasive, cfDNA‑based liquid biopsy platform for dogs that integrates next‑generation sequencing and proprietary algorithms to provide multi‑cancer early detection, residual disease monitoring, and recurrence surveillance from a simple blood sample. Its validated multi‑cancer panel, supported by broad clinical data and now expanded with a lower‑cost screening variant (OncoK9® Screen), enables veterinarians to detect and track cancer signals across diverse tumor types earlier and more comprehensively than traditional diagnostics alone.